Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

BAY12-8039: 5 Days for Sinusitis vs Placebo

ClinicalTrials.gov ID: NCT00492024

Public ClinicalTrials.gov record NCT00492024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective, Multicenter, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Moxifloxacin 400 mg QD for 5 Days Versus Placebo in the Treatment of Acute Bacterial Sinusitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the effectiveness and safety of Avelox in a 5 day treatment of adult patients with acute bacterial sinusitis and to measure the amount of time it takes for symptom relief. Avelox is currently not approved for the 5 day treatment of acute bacterial sinusitis, therefore in this study Avelox is considered an investigational drug. In this study Avelox will be compared to placebo.

Study identification

NCT ID
NCT00492024
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
374 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2005 (Type not available)
Primary completion
Mar 2008 (Actual)
Completion
Mar 2008 (Actual)
Last update posted
Nov 26, 2013

2005 – 2008

United States locations

U.S. sites
51
U.S. states
22
U.S. cities
48
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209 —
Not listed Northport Alabama 35476 —
Not listed Jonesboro Arkansas 72401 —
Not listed Little Rock Arkansas 72205 —
Not listed Fresno California 93710 —
Not listed Fresno California 93720 —
Not listed Garden Grove California 92840 —
Not listed Orange California 92868 —
Not listed Roseville California 95678 —
Not listed San Diego California 92106 —
Not listed San Luis Obispo California 93405 —
Not listed Colorado Springs Colorado 80909 —
Not listed Bridgeport Connecticut 06606 —
Not listed Dunnellon Florida 34432 —
Not listed Hialeah Florida 33013 —
Not listed North Miami Beach Florida 33179 —
Not listed Pembroke Pines Florida 33024 —
Not listed Plantation Florida 33324 —
Not listed Atlanta Georgia 30310 —
Not listed Warner Robbins Georgia 31093 —
Not listed Warner Robins Georgia 31088 —
Not listed Louisville Kentucky 40207 —
Not listed Detroit Michigan 48202 —
Not listed Livonia Michigan 48152 —
Not listed Portage Michigan 49024 —
Not listed Butte Montana 59701 —
Not listed Elizabeth New Jersey 07202-3672 —
Not listed Lawrenceville New Jersey 08698 —
Not listed Somerville New Jersey 08876 —
Not listed Rochester New York 14618 —
Not listed Charlotte North Carolina 28210 —
Not listed Raleigh North Carolina 27609 —
Not listed Cincinnati Ohio 45241 —
Not listed Dayton Ohio 45406 —
Not listed Eugene Oregon 97404 —
Not listed Levittown Pennsylvania 19056 —
Not listed Norristown Pennsylvania 19401 —
Not listed Palmyra Pennsylvania 17078 —
Not listed Clarksville Tennessee 37043 —
Not listed Austin Texas 78705 —
Not listed College Station Texas 77845 —
Not listed El Paso Texas 79904 —
Not listed Houston Texas 77074 —
Not listed San Antonio Texas 78229 —
Not listed Salt Lake City Utah 84109 —
Not listed Salt Lake City Utah 84121 —
Not listed West Jordan Utah 84084 —
Not listed West Jordan Utah 84088 —
Not listed Tappahannock Virginia 22560 —
Not listed Bellingham Washington 98225 —
Not listed Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00492024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2013 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00492024 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →